ArriVent BioPharma (AVBP) Other Working Capital Changes (2024 - 2026)
ArriVent BioPharma (AVBP) reported Other Working Capital Changes of $47000.0 for Q1 2026, up 1275.0% on a YoY basis from $3418.2 in Q1 2025, and up 1040.0% sequentially from -$5000.0 in Q4 2025.
ArriVent BioPharma (AVBP) Other Working Capital Changes (2024 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 3 years of Other Working Capital Changes data on file, last reported at $47000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 1275.0% year-over-year to $47000.0; the trailing twelve-month figure through Mar 2026 stood at $30000.0 (up 287.5% YoY), and the FY2025 full-year result was -$21000.0, down 950.0% from the prior year.
- Other Working Capital Changes rose to $47000.0 in Q1 2026, from -$5000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.5 million in Q3 2025 to a low of -$3.4 million in Q2 2023.
- A 4-year average of $967615.4 and a median of $3000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 140.0% in 2025 and jumped 1275.0% in 2026, its largest moves.
- Tracing AVBP's Other Working Capital Changes over 3 years: stood at -$4000.0 in 2024, then dropped by 25.0% to -$5000.0 in 2025, then surged by 1040.0% to $47000.0 in 2026.
- Business Quant data shows AVBP's Other Working Capital Changes at $47000.0 in Q1 2026, -$5000.0 in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |